Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

FAM134B-mediated ER-phagy degrades APP and suppresses Alzheimer's disease pathology.
Clinical and laboratory findings in patients with anti-myelin oligodendrocyte glycoprotein antibodies: experience from two tertiary hospitals in Madrid.
Type 1 Diabetes and Multiple Sclerosis Share General Autoimmunity Genetic Variation.
Machine learning-driven drug repurposing for GPR17: activity prediction via graph neural networks and multistage computational validation.
Ultrasound-Confirmed Median Nerve Pseudoconduction Block due to Anatomical Variation.
Temporal trends in the incidence and prevalence of multiple sclerosis in Sweden 2001-2021.
Benefits of 12-week self-paced training combined with melatonin supplementation on oxidative stress, inflammation, hyperlipidemia, and body composition in multiple sclerosis patients: a randomized controlled trial.
TSPO-PET-measurable neuroinflammation associates with information processing speed decline in multiple sclerosis.
What if it is the eyes? The effect of eye movement disorders on cognitive testing in MS.
Glial cells in chronic inflammation: diversity, dysfunction and therapeutic targeting.
Reliable Change Indices and Standardized Regression Norms for the Hungarian version of the BICAMS questionnaire.
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Onset in Pregnancy: A Case Report.
Machine Learning and AI Applied to fNIRS Data Reveals Novel Brain Activity Biomarkers in Stable Subclinical Multiple Sclerosis.
A Pre-symptomatic phase of tumefactive multiple sclerosis mirrors radiologically isolated syndrome.
Looking Beyond Dose: Identifying Responders and Non-Responders to RehaCom Computerized Cognitive Rehabilitation in Progressive MS-The CogEx Study.
The clinical significance of S100B, APP, and CHI3L1 in autoimmune GFAP astrocytopathy.
The role of Epstein-Barr virus in multiple sclerosis: From pathogenesis to therapeutic potential.
Risk of Multiple Sclerosis Among Persons with Epstein Barr Virus-Positive Mononucleosis: A Population-Based Study.
The p.(Leu97Ile) variant expands the genetic landscape of NEFL-associated Charcot-Marie-tooth neuropathies.
Neurocysticercosis by Taenia sp. in a female alpaca (Vicugna pacos) from Germany.
Comment on "Spinal cord metabolism in multiple sclerosis: a decade of missed opportunities and future directions".
Amyotrophic lateral sclerosis and chronic inflammatory demyelinating polyneuropathy coexistence in a patient with a C9orf72 variant: case report.
Neurology Wait Times After Primary Care or Emergency Department Visits Among the Commercially Insured Population in the United States: 2019-2023.
Beyond serology: clinical and prognostic determinants in patients with dual AQP4-IgG and MOG-IgG seropositivity.
No interferon-beta antibodies in natalizumab-treated multiple sclerosis patients with progressive multifocal leukoencephalopathy.

Pages